DOWNSTREAM PROCESSING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Regional Analysis

To learn more about this report, request a free sample copy

North America has dominated the downstream processing market for many years owing to strong presence of leading biopharmaceutical companies in the region and is estimated to account for a high share of 39.3 % in 2024. The U.S. accounts for majority of the market share in North America. Strong focus on innovation along with growing biologics sector has propelled the growth. Presence of well-established CMOs who offer wide range of downstream services has further boosted the regional market growth.

Many biopharma companies in the region have been focusing on the development of complex biologics which involves extensive downstream processing. This provides impetus to CMOs to invest in state-of-the-art technologies for large-scale purification and manufacturing of such products. Growing interest of small companies in outsourcing downstream activities to well-equipped CMOs supplements the regional market size.

Asia Pacific region has emerged as the fastest growing market for downstream processing in recent years. Rapid expansion of biopharmaceutical industry across major APAC countries including China, India, South Korea and others drives significant growth opportunities. Governments across APAC are partnering with global players to set up manufacturing facilities which will augment regional market.